Working to facilitate rapid translation of scientific discoveries into therapeutics

Hugo Geerts

hugo

Hugo Geerts, PhD

Hugo Geerts is currently Chief Scientific Officer of In Silico Biosciences, a company that provides mechanistic disease modeling services in CNS Drug discovery & Development. After an undergraduate degree in physics (theoretical quantum-mechanics) and a PhD in Biophysics he got a Bachelor Degree in Medicine, a Master in Pharmaceutical Sciences, and a Pharma Executive MBA at Drexel University in Philadelphia. He worked for 17 years with Dr. Paul Janssen, probably the greatest drug hunter in history at the Janssen Research Foundation (part of J&J) where he headed the Alzheimer Discovery research with programs in tangle and b-amyloid pathology and supported the succesfull clinical development of galantamine. He is passionate about the need for more translational modeling & simulation along the whole Drug R&D process to reduce the failure rate of clinical trials and to get better drugs faster to the right patients. He is currently also on the faculty of the Perelman School of Medicine (University of Pennsylvania) and the Drexel University Dept of Pharmacology.

2013-2021©European Society for Translational Medicine (EUSTM)